HYBRID EVENT: You can participate in person at Boston, Massachusetts, USA or Virtually from your home or work.
Pratima Tripathi, Speaker at Diabetes Conference
National Institute of Pharmaceutical Education and Research (NIPER), India
Title : Vascular dysfunction and diabetes mellitus: a pathophysiological association

Abstract:

Points of Discussion: Prevalence of Diabetes, Effect of Diabetes on vascular dysfunction, Biomarkers targeting vascular dysfunction in diabetic condition, possible treatments.
There are around 100 million people worldwide who have diabetes mellitus. 5% to 10% of people have type 1 diabetes, also known as insulin-dependent diabetes, while 90% to 95% have type 2 diabetes, also known as non-insulin-dependent diabetes. As a result of lifestyle choices causing obesity, type 2 diabetes incidence is probably going to increase. As vascular disorders are the leading causes of mortality and disability among diabetics, cardiovascular specialists are seeing a lot of these patients. Atherosclerosis and medial calcification are examples of the macrovascular manifestations. Retinopathy and nephropathy, which are microvascular sequelae, are significant contributors to blindness and end-stage renal failure. To best treat these patients, doctors must be aware of the key characteristics of diabetic vascular disease.

In a healthy state, endogenous reparative activities reduce endothelial cell damage. Patients with diabetes have an imbalance between repair and damage, which causes micro-vascular alterations, including micro-vascular cell death, which eventually culminates in problems from diabetes. Changes in proliferation, barrier function, adherence of other circulating cells, and susceptibility to apoptosis are indicative of endothelial dysfunction in diabetes mellitus. The angiogenic and synthetic capacities of endothelial cells may also be altered by diabetes mellitus.

Research on biomarkers is also pacing up to find out some innovative combinations or target molecules to be treated as biomarkers and is capable of showing it’s efficiency throughout the course of the disease.
In her talk the speaker will focus on the Prevalence of Diabetes, Effect of Diabetes on vascular dysfunction.
Biomarkers targeting vascular dysfunction in diabetic condition and possible treatments

Audience Takeaway:

  • Through this talk the research and student community will understand the significance of endothelium and it’s direct involvement in peripheral vascular disease.
  • They will understand Dysfunction of the vascular endothelium is a hallmark of human diseases and hence will apply the concept in their advanced research assignments.
  • Targeting the biomarkers/changing parameters could be used in the development/discovery of biomarkers in vascular diseases.

Biography:

Dr. Pratima Tripathi attained her Ph.D. degree in 2012 from University of Lucknow, Uttar Pradesh, India. Post Ph.D she worked as faculty at different organisations for 7 years after which she choose to pursued her research career as Postdoctoral Fellow from 2019 till 2021 at Dr. Ram Manohar Lohia Institute of Medical Sciences, Lucknow, Uttar Pradesh, India. Currently she is a faculty at National Institute of Pharmaceutical Education and Research (NIPER) Raebareli, Uttar Pradesh, India. She has an expertise in clinical biochemistry and translational research. She has worked on diabetes induced vascular dysfunction, cardiovascular disorders, the underlying mechanism of CVD and development of suitable biomarkers for screening of the disease and its treatment.  At NIPER, her research team is targeting to design suitable drugs/drug conjugates to treat inflammation in diseases specially CVD and also to study the inflammatory pathways that exaggerate the diseased condition leading to the insult of the normal body physiology.

Watsapp